Your browser doesn't support javascript.
loading
Real-world study of the effectiveness of BBIBP-CorV (Sinopharm) COVID-19 vaccine in the Kingdom of Morocco.
Zhang, Yaowen; Belayachi, Jihane; Yang, Yunkai; Fu, Qiang; Rodewald, Lance; Li, Hongling; Yan, Bing; Wang, Ying; Shen, Yanna; Yang, Qian; Mu, Weiyun; Tang, Rong; Su, Chen; Xu, Tianfang; Obtel, Majdouline; Mhayi, Abdelkader; Razine, Rachid; Abouqal, Redouane; Zhang, Yuntao; Yang, Xiaoming.
Afiliação
  • Zhang Y; China National Biotec Group Company Limited, B2 Shuangqiao Rd, Chaoyang District, Beijing, P.R. China.
  • Belayachi J; Acute Medical Unit, Ibn Sina University Hospital, Rabat, Morocco.
  • Yang Y; Laboratory of Biostatistics, Clinical, and Epidemiological Research, Department of Public Health, Faculty of Medicine and Pharmacy, Mohammed V University in Rabat, Rabat, Morocco.
  • Fu Q; China National Biotec Group Company Limited, B2 Shuangqiao Rd, Chaoyang District, Beijing, P.R. China.
  • Rodewald L; China Sinopharm International Corporation, Beijing, P.R. China.
  • Li H; Chinese Center for Disease Control and Prevention, National Immunization Program, Beijing, P.R. China.
  • Yan B; China National Biotec Group Company Limited, B2 Shuangqiao Rd, Chaoyang District, Beijing, P.R. China.
  • Wang Y; China Sinopharm International Corporation, Beijing, P.R. China.
  • Shen Y; China Sinopharm International Corporation, Beijing, P.R. China.
  • Yang Q; China National Biotec Group Company Limited, B2 Shuangqiao Rd, Chaoyang District, Beijing, P.R. China.
  • Mu W; China National Biotec Group Company Limited, B2 Shuangqiao Rd, Chaoyang District, Beijing, P.R. China.
  • Tang R; China National Biotec Group Company Limited, B2 Shuangqiao Rd, Chaoyang District, Beijing, P.R. China.
  • Su C; China National Biotec Group Company Limited, B2 Shuangqiao Rd, Chaoyang District, Beijing, P.R. China.
  • Xu T; China Sinopharm International Corporation, Beijing, P.R. China.
  • Obtel M; China National Biotec Group Company Limited, B2 Shuangqiao Rd, Chaoyang District, Beijing, P.R. China.
  • Mhayi A; Laboratory of Biostatistics, Clinical, and Epidemiological Research, Department of Public Health, Faculty of Medicine and Pharmacy, Mohammed V University in Rabat, Rabat, Morocco.
  • Razine R; Laboratory of Community Health (Public Health, Preventive Medicine and Hygiene), Department of Public Health, Faculty of Medicine and Pharmacy, Mohammed V University in Rabat, Rabat, Morocco.
  • Abouqal R; Department of Informatics, Ministry of Health and Social Protection, Rabat, Morocco.
  • Zhang Y; Laboratory of Biostatistics, Clinical, and Epidemiological Research, Department of Public Health, Faculty of Medicine and Pharmacy, Mohammed V University in Rabat, Rabat, Morocco.
  • Yang X; Laboratory of Community Health (Public Health, Preventive Medicine and Hygiene), Department of Public Health, Faculty of Medicine and Pharmacy, Mohammed V University in Rabat, Rabat, Morocco.
BMC Public Health ; 22(1): 1584, 2022 08 20.
Article em En | MEDLINE | ID: mdl-35987605
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Vacinas contra Influenza / COVID-19 Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adolescent / Adult / Aged / Aged80 / Humans / Middle aged País como assunto: Africa Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Vacinas contra Influenza / COVID-19 Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adolescent / Adult / Aged / Aged80 / Humans / Middle aged País como assunto: Africa Idioma: En Ano de publicação: 2022 Tipo de documento: Article